Advances in Retinopathy of Prematurity / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 261-266, 2019.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-776040
Biblioteca responsable:
WPRO
ABSTRACT
Retinopathy of prematurity(ROP)is a pathological neovascularization with fibrotic changes in the fundus of premature infants.It is a major cause of preventable blindness in children in both developing and developed countries.Treatment of ROP has long been a hot research topic in ophthalmology and pediatrics.With a clearer knowledge of the pathogenesis of ROP,more basic and clinical studies have been carried out.The anti-vascular endothelial growth factor therapy and surgical treatment have become mature strategies,and a variety of therapeutic drugs including insulin-like growth factor-1,transforming growth factor-β,polyunsaturated fatty acids,and β-adrenergic receptor blockers have been developed.This article reviews the recent advances in ROP.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Asunto principal:
Cirugía General
/
Terapéutica
/
Retinopatía de la Prematuridad
/
Recien Nacido Prematuro
/
Factor A de Crecimiento Endotelial Vascular
/
Quimioterapia
/
Neovascularización Patológica
Límite:
Niño
/
Humanos
/
Recién nacido
Idioma:
Chino
Revista:
Acta Academiae Medicinae Sinicae
Año:
2019
Tipo del documento:
Artículo